MedTrace Logo

Formula Diet Treatment for NASH Patients.

NCT04707651 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-07-11

No results posted yet for this study

Summary

Non-alcoholic steatohepatitis (NASH) - also called fatty liver - is medically a serious problem because the liver tissue becomes fatty and stiff, and inflammatory reactions occur. This increases the risk of liver fibrosis (= scarring of the liver), liver cirrhosis (= shrunken liver), a liver tumor or death. So far there is no recognized treatment option for this disease. However, there is evidence that a lifestyle change based on a reduced carbohydrate diet, more exercise and a significant weight loss that can improve NASH.

Conditions

  • Steatohepatitis, Nonalcoholic

Interventions

DIETARY_SUPPLEMENT

Formula diet

Formula diet for 12 weeks

Sponsors & Collaborators

  • West German Center of Diabetes and Health

    lead OTHER

Principal Investigators

  • Stephan Martin, MD · West-German Centre of Diabetes and Health

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2024-12-31
Completion
2025-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04707651 on ClinicalTrials.gov